Whole-Brain Radiotherapy vs. Localized Radiotherapy after Resection of Brain Metastases in the Era of Targeted Therapy: A Retrospective Study

Whole-Brain Radiotherapy vs. Localized Radiotherapy after Resection of Brain Metastases in the Era of Targeted Therapy: A Retrospective Study

Whether targeted therapy (TT) and radiotherapy impact survival after resection of brain metastases (BM) is unknown. The purpose of this study was to analyze the factors affecting overall survival (OS), local control (LC), distant control (DC), and leptomeningeal metastases (LMM) in patients who had...

Full description

Bibliographic Details
Main Authors:	Jaho Koo, Tae Hoon Roh, Sang Ryul Lee, Jaesung Heo, Young-Taek Oh, Se-Hyuk Kim
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Cancers
Subjects:	brain metastases radiosurgery targeted therapy survival surgery
Online Access:	https://www.mdpi.com/2072-6694/13/18/4711

Similar Items

Radiotherapy management of brain metastases using conventional linear accelerator
by: Marcel Matzenauer, et al.
Published: (2016-09-01)

Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases—Implications for Intraoperative Radiotherapy after Resection
by: Carsten Herskind, et al.
Published: (2017-07-01)

The Cognitive Effects of Radiotherapy for Brain Metastases
by: Eric J. Lehrer, et al.
Published: (2022-06-01)

Repeated Stereotactic Radiotherapy for Local Brain Metastases Failure or Distant Brain Recurrent: A Retrospective Study of 184 Patients
by: Laure Kuntz, et al.
Published: (2023-10-01)

Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases
by: Sofian Benkhaled, et al.
Published: (2024-03-01)

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
by: Jaap D. Zindler, et al.
Published: (2017-07-01)

Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients
by: L. Kuntz, et al.
Published: (2023-01-01)

Acute toxicities and cumulative dose to the brain of repeated sessions of stereotactic radiotherapy (SRT) for brain metastases: a retrospective study of 184 patients
by: L. Kuntz, et al.
Published: (2023-01-01)

Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review
by: Maxime Loo, et al.
Published: (2021-12-01)

Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
by: Corinna Fritz, et al.
Published: (2018-11-01)

Neurotoxicity-sparing radiotherapy for brain metastases in breast cancer: a narrative review
by: Dagmara Buczek, et al.
Published: (2024-02-01)

In response to Fogarty et al. and why adjuvant whole brain radiotherapy is not recommended routinely
by: Mark B. Pinkham, et al.
Published: (2017-11-01)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2020-12-01)

Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
by: Dominik Oft, et al.
Published: (2021-01-01)

Neoadjuvant Stereotactic Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis of the Literature and Ongoing Clinical Trials
by: Paolo Palmisciano, et al.
Published: (2022-09-01)

Sector Irradiation vs. Whole Brain Irradiation After Resection of Singular Brain Metastasis—A Prospective Randomized Monocentric Trial
by: Johannes Kerschbaumer, et al.
Published: (2020-11-01)

Brain metastases: Whom, when and for which lesions should we operate?
by: N. Sakellaridis, et al.
Published: (2017-01-01)

Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial
by: Maria Waltenberger, et al.
Published: (2023-07-01)

Efficiency of Stereotactic Conformal Radiotherapy in Lung Metastases with Active Breathing Control
by: Olga Yu. Anikeeva, PhD, et al.
Published: (2013-06-01)

Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives
by: Loi M, et al.
Published: (2019-11-01)

Frameless stereotaxic radiosurgery for multiple brain metastases
by: Diкаn I.N., et al.
Published: (2014-06-01)

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
by: Giuseppe Minniti, et al.
Published: (2019-04-01)

Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab
by: Tijana Skrepnik, et al.
Published: (2017-03-01)

Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study
by: Pierina Navarria, et al.
Published: (2023-02-01)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
by: Xue-Yi Xie, et al.
Published: (2022-07-01)

Overall survival following stereotactic radiosurgery for ten or more brain metastases: a systematic review and meta-analysis
by: Hamoun Rozati, et al.
Published: (2023-10-01)

Heterogeneity of HER2 Expression in Circulating Tumor Cells of Patients with Breast Cancer Brain Metastases and Impact on Brain Disease Control
by: Douglas Guedes de Castro, et al.
Published: (2022-06-01)

Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases
by: N. Bachmann, et al.
Published: (2019-03-01)

Predictors for long-term survival free from whole brain radiation therapy in patients treated with radiosurgery for limited brain metastases
by: Daniel eGorovets, et al.
Published: (2015-05-01)

Radiation therapy for melanoma brain metastases: a systematic review
by: Thompson John F., et al.
Published: (2022-08-01)

Mining Prognosis Index of Brain Metastases Using Artificial Intelligence
by: Shigao Huang, et al.
Published: (2019-08-01)

Description of brain metastasis response and ad-verse effects to CyberKnife® treatment
by: Araujo-Reyes, Ana Teresa, et al.
Published: (2020-10-01)

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
by: Raees Tonse, et al.
Published: (2021-07-01)

Preoperative stereotactic radiosurgery in the management of brain metastases and gliomas
by: Eric J. Lehrer, et al.
Published: (2022-10-01)

Single Institutional Experience of Stereotactic Radiosurgery Alone for First Brain Metastatic Event and Salvage of Second Brain Metastatic Event in a Community Setting with Review of the Literature
by: Shaharyar Ahmad, et al.
Published: (2017-03-01)

Pre-operative stereotactic radiosurgery treatment is preferred to post-operative treatment for smaller solitary brain metastases
by: Hamidreza Aliabadi, et al.
Published: (2017-10-01)

Efficacy of pre-operative stereotactic radiosurgery followed by surgical resection and correlative radiobiological analysis for patients with 1–4 brain metastases: study protocol for a phase II trial
by: Wei X. Huff, et al.
Published: (2018-12-01)

Treatment of brain metastases
by: Marcel Matzenauer, et al.
Published: (2016-12-01)

Opportunities and Alternatives of Modern Radiation Oncology and Surgery for the Management of Resectable Brain Metastases
by: Christian D. Diehl, et al.
Published: (2023-07-01)